Custom Search


Portfolio of Biotech Stocks: Cancer

Here is a sample of 18 biotech stocks that provide cancer detection and treatments.

Biotech Stocks: Cancer
Stock
Price Quote & Dividend
Recent Dividends
1-Yr Price Chart
Amgen
Ariad Pharmaceuticals
Array BioPharma
Celgene
Celldex Therapeutics
Endocyte
Exelixis
ImmunoCellular Therapeutics
ImmunoGen
Incyte Corporation
Juno Therapeutics
Medivation
OncoMed Pharmaceuticals
Puma Biotechnology
SciClone Pharmaceuticals
Seattle Genetics
Spectrum Pharmaceuticals
Tesaro
Price and dividend data from Quandl.


To inspect the performance of the Biotech Stocks: Cancer portfolio, see the returns table and chart below. Portfolio values are computed using quarterly closes from Quandl.

The 13 stocks included in the portfolio computations are: AMGN, ARIA, ARRY, CELG, CLDX, EXEL, IMUC, IMGN, INCY, MDVN, SCLN, SGEN and SPPI. The current value of the portfolio assumes that $769.23 was invested (total of $10,000) in each at its closing quarterly price for the current date in 2007. The 5 stocks excluded from the portfolio computations because prices started after 2007: ECYT, JUNO, OMED, PBYI and TSRO.


Biotech Stocks: Cancer - Return Results
Portfolio:
Biotech Stocks: Cancer
Start date:
Aug-16-2007
Start value:
$10,000
End date:
Aug-16-2017
End value:
$57,702
Number prices
37
Minimum value occurred on Dec-31-2008
$7,750
Maximum value occurred on Sep-30-2017
$57,702
Total gain or loss (Start date to End date)
477.02%
Annualized gain or loss (Start date to End date)
20.86%
Total dollar value on End date of a $10,000 purchase made on Start date
$57,702
Average percent return for all possible buy/sell combinations
91.72%
Number returns
666
Number profitable returns (Winners)
575
Percent profitable returns
86.34%
Number unprofitable returns (Losers)
91
Percent unprofitable returns
13.66%
Winners to losers ratio
6.32
See Multiyear Chart of Monthly Portfolio Values


Related Articles

Portfolio of Big Pharmaceuticals Stocks: Cancer
Portfolio of Biotech Stocks
Portfolio of Biotech Stocks: Arthritis
Portfolio of Biotech Stocks: Diabetes
Portfolio of Biotech Stocks: Hepatitis C
Portfolio of Dividend-Paying Pharmaceutical Stocks
Portfolio of Generic Drug Stocks